Multivariate AnalysisAge FactorsPrognosisRetrospective StudiesRisk FactorsTreatment OutcomeSurvival AnalysisSurvival RateFollow-Up StudiesProspective StudiesPredictive Value of TestsProportional Hazards ModelsLogistic ModelsDisease-Free SurvivalNeoplasm StagingKaplan-Meier EstimateTime FactorsCohort StudiesTumor Markers, BiologicalCross-Sectional StudiesAnalysis of VarianceRegression AnalysisRisk AssessmentOdds RatioNeoplasm Recurrence, LocalLymphatic MetastasisCase-Control StudiesPrevalenceRecurrenceChi-Square DistributionSex FactorsIncidenceBreast NeoplasmsSeverity of Illness IndexImmunohistochemistryQuestionnairesDisease ProgressionCombined Modality TherapyBiological MarkersUnited StatesSocioeconomic FactorsAntineoplastic Combined Chemotherapy ProtocolsAdenocarcinomaLiver NeoplasmsPostoperative ComplicationsROC CurveLinear ModelsLung NeoplasmsComorbidityNeoplasm InvasivenessJapanEpidemiologic MethodsSmokingHIV InfectionsColorectal NeoplasmsRiskFranceInfant, NewbornChemotherapy, AdjuvantPrincipal Component AnalysisCarcinoma, Squamous CellBody Mass IndexTissue Array AnalysisLongitudinal StudiesTreatment FailureCarcinoma, HepatocellularSensitivity and SpecificityHospital MortalityItalyRegistriesStomach NeoplasmsKi-67 AntigenNeoplasm MetastasisConfidence IntervalsReproducibility of ResultsBrazilProbabilityNeoplasm GradingGenotypeChinaDiscriminant AnalysisAcute DiseaseDemographyAge DistributionMyocardial InfarctionRadiotherapy, AdjuvantSpainChronic DiseaseCarcinoma, Non-Small-Cell LungProstatic NeoplasmsCarcinomaRemission InductionEsophageal NeoplasmsStatistics as TopicHepatectomyLymph Node ExcisionC-Reactive ProteinCyclophosphamideLength of StaySex Distribution